US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist

0.368
+0.028+8.23%

Close Nov 21 16:00 ET

62.83MMarket Cap-4605P/E (TTM)

X4 Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

560K

563K

Operating revenue

--560K

--563K

--0

Cost of revenue

227K

268K

Gross profit

333K

295K

Operating expense

28.00%34.83M

32.50%34.19M

27.25%37.29M

22.08%107.52M

-1.48%25.2M

35.03%27.21M

25.45%25.81M

34.56%29.3M

16.89%88.08M

32.54%25.58M

Selling and administrative expenses

92.55%15.66M

30.13%13.28M

140.78%17.44M

31.40%35.51M

51.26%9.93M

34.56%8.13M

51.19%10.2M

-5.52%7.24M

9.38%27.02M

-8.02%6.56M

Research and development costs

0.48%19.17M

34.06%20.91M

-10.01%19.85M

17.95%72.02M

-19.68%15.27M

35.23%19.08M

12.88%15.6M

56.33%22.06M

20.56%61.06M

56.34%19.01M

Operating profit

-26.77%-34.5M

-31.36%-33.9M

-27.25%-37.29M

-22.08%-107.52M

1.48%-25.2M

-35.03%-27.21M

-25.45%-25.81M

-34.56%-29.3M

-16.89%-88.08M

-32.54%-25.58M

Net non-operating interest income expense

-120.73%-543K

-161.11%-611K

-194.89%-808K

68.34%-1.2M

53.38%-441K

75.50%-246K

74.40%-234K

69.89%-274K

-3.91%-3.77M

-2.60%-946K

Non-operating interest income

34.80%1.87M

71.23%1.57M

27.66%1.07M

1,992.24%4.58M

629.80%1.45M

9,814.29%1.39M

22,750.00%914K

27,733.33%835K

2,090.00%219K

6,500.00%198K

Non-operating interest expense

47.74%2.41M

89.55%2.18M

68.98%1.87M

44.68%5.78M

64.86%1.89M

60.51%1.63M

25.05%1.15M

21.47%1.11M

9.64%3.99M

23.68%1.14M

Other net income (expense)

-106.50%-1.64M

522.68%125.36M

-345.42%-13.65M

483.90%7.63M

354.89%6.54M

5,809.98%25.18M

-10,845.65%-29.66M

646.58%5.56M

79.51%-1.99M

74.29%-2.57M

Gain on sale of security

-107.41%-1.86M

167.70%20.22M

-352.90%-13.76M

315.87%7.07M

432.02%6.33M

--25.16M

-9,013.43%-29.86M

2,990.34%5.44M

564.75%1.7M

460.61%1.19M

Special income (charges)

--0

--105M

----

--0

----

105.22%509K

--0

-Less:Impairment of capital assets

----

--0

----

--0

----

-Gain on sale of property,plant,equipment

--0

--105M

----

--0

----

--509K

--0

Other non- operating income (expenses)

1,229.41%226K

-28.71%144K

-14.63%105K

113.20%554K

105.64%212K

103.85%17K

442.37%202K

105.00%123K

-1,085.21%-4.2M

-3,747.57%-3.76M

Income before tax

-1,509.52%-36.68M

263.12%90.85M

-115.47%-51.75M

-7.73%-101.09M

34.35%-19.1M

89.45%-2.28M

-162.62%-55.7M

-9.45%-24.02M

-5.82%-93.84M

3.69%-29.09M

Income tax

-42.31%15K

20.00%18K

375.00%19K

178.57%78K

135.71%33K

300.00%26K

275.00%15K

-82.61%4K

64.71%28K

366.67%14K

Net income

-1,492.02%-36.7M

263.04%90.83M

-115.51%-51.77M

-7.78%-101.17M

34.27%-19.13M

89.32%-2.31M

-162.64%-55.71M

-9.36%-24.02M

-5.83%-93.87M

3.65%-29.1M

Net income continuous Operations

-1,492.02%-36.7M

263.04%90.83M

-115.51%-51.77M

-7.78%-101.17M

34.27%-19.13M

89.32%-2.31M

-162.64%-55.71M

-9.36%-24.02M

-5.83%-93.87M

3.65%-29.1M

Minority interest income

Net income attributable to the parent company

-1,492.02%-36.7M

263.04%90.83M

-115.51%-51.77M

-7.78%-101.17M

34.27%-19.13M

89.32%-2.31M

-162.64%-55.71M

-9.36%-24.02M

-5.83%-93.87M

3.65%-29.1M

Preferred stock dividends

Other preferred stock dividends

-81.74%2.55M

Net income attributable to common stockholders

-1,492.02%-36.7M

263.04%90.83M

-115.51%-51.77M

-4.93%-101.17M

34.27%-19.13M

89.46%-2.31M

-162.64%-55.71M

0.84%-24.02M

6.07%-96.41M

18.96%-29.1M

Basic earnings per share

-1,700.00%-0.18

236.36%0.45

-62.50%-0.26

62.50%-0.57

68.97%-0.09

96.15%-0.01

45.00%-0.33

77.78%-0.16

61.90%-1.52

76.61%-0.29

Diluted earnings per share

-1,700.00%-0.18

236.36%0.45

-62.50%-0.26

62.50%-0.57

68.97%-0.09

96.15%-0.01

45.00%-0.33

77.78%-0.16

61.90%-1.52

76.61%-0.29

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	560K	563K	0	0	0	0	0	0	0	0
Operating revenue	--560K	--563K	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue	227K	268K				0	0
Gross profit	333K	295K				0	0
Operating expense	28.00%34.83M	32.50%34.19M	27.25%37.29M	22.08%107.52M	-1.48%25.2M	35.03%27.21M	25.45%25.81M	34.56%29.3M	16.89%88.08M	32.54%25.58M
Selling and administrative expenses	92.55%15.66M	30.13%13.28M	140.78%17.44M	31.40%35.51M	51.26%9.93M	34.56%8.13M	51.19%10.2M	-5.52%7.24M	9.38%27.02M	-8.02%6.56M
Research and development costs	0.48%19.17M	34.06%20.91M	-10.01%19.85M	17.95%72.02M	-19.68%15.27M	35.23%19.08M	12.88%15.6M	56.33%22.06M	20.56%61.06M	56.34%19.01M
Operating profit	-26.77%-34.5M	-31.36%-33.9M	-27.25%-37.29M	-22.08%-107.52M	1.48%-25.2M	-35.03%-27.21M	-25.45%-25.81M	-34.56%-29.3M	-16.89%-88.08M	-32.54%-25.58M
Net non-operating interest income expense	-120.73%-543K	-161.11%-611K	-194.89%-808K	68.34%-1.2M	53.38%-441K	75.50%-246K	74.40%-234K	69.89%-274K	-3.91%-3.77M	-2.60%-946K
Non-operating interest income	34.80%1.87M	71.23%1.57M	27.66%1.07M	1,992.24%4.58M	629.80%1.45M	9,814.29%1.39M	22,750.00%914K	27,733.33%835K	2,090.00%219K	6,500.00%198K
Non-operating interest expense	47.74%2.41M	89.55%2.18M	68.98%1.87M	44.68%5.78M	64.86%1.89M	60.51%1.63M	25.05%1.15M	21.47%1.11M	9.64%3.99M	23.68%1.14M
Other net income (expense)	-106.50%-1.64M	522.68%125.36M	-345.42%-13.65M	483.90%7.63M	354.89%6.54M	5,809.98%25.18M	-10,845.65%-29.66M	646.58%5.56M	79.51%-1.99M	74.29%-2.57M
Gain on sale of security	-107.41%-1.86M	167.70%20.22M	-352.90%-13.76M	315.87%7.07M	432.02%6.33M	--25.16M	-9,013.43%-29.86M	2,990.34%5.44M	564.75%1.7M	460.61%1.19M
Special income (charges)	--0	--105M	----	--0	--0	--0	--0	----	105.22%509K	--0
-Less:Impairment of capital assets	----	----	----	--0	----	----	----	----	--0	----
-Gain on sale of property,plant,equipment	--0	--105M	----	--0	--0	--0	--0	----	--509K	--0
Other non- operating income (expenses)	1,229.41%226K	-28.71%144K	-14.63%105K	113.20%554K	105.64%212K	103.85%17K	442.37%202K	105.00%123K	-1,085.21%-4.2M	-3,747.57%-3.76M
Income before tax	-1,509.52%-36.68M	263.12%90.85M	-115.47%-51.75M	-7.73%-101.09M	34.35%-19.1M	89.45%-2.28M	-162.62%-55.7M	-9.45%-24.02M	-5.82%-93.84M	3.69%-29.09M
Income tax	-42.31%15K	20.00%18K	375.00%19K	178.57%78K	135.71%33K	300.00%26K	275.00%15K	-82.61%4K	64.71%28K	366.67%14K
Net income	-1,492.02%-36.7M	263.04%90.83M	-115.51%-51.77M	-7.78%-101.17M	34.27%-19.13M	89.32%-2.31M	-162.64%-55.71M	-9.36%-24.02M	-5.83%-93.87M	3.65%-29.1M
Net income continuous Operations	-1,492.02%-36.7M	263.04%90.83M	-115.51%-51.77M	-7.78%-101.17M	34.27%-19.13M	89.32%-2.31M	-162.64%-55.71M	-9.36%-24.02M	-5.83%-93.87M	3.65%-29.1M
Minority interest income
Net income attributable to the parent company	-1,492.02%-36.7M	263.04%90.83M	-115.51%-51.77M	-7.78%-101.17M	34.27%-19.13M	89.32%-2.31M	-162.64%-55.71M	-9.36%-24.02M	-5.83%-93.87M	3.65%-29.1M
Preferred stock dividends
Other preferred stock dividends				0					-81.74%2.55M	0
Net income attributable to common stockholders	-1,492.02%-36.7M	263.04%90.83M	-115.51%-51.77M	-4.93%-101.17M	34.27%-19.13M	89.46%-2.31M	-162.64%-55.71M	0.84%-24.02M	6.07%-96.41M	18.96%-29.1M
Basic earnings per share	-1,700.00%-0.18	236.36%0.45	-62.50%-0.26	62.50%-0.57	68.97%-0.09	96.15%-0.01	45.00%-0.33	77.78%-0.16	61.90%-1.52	76.61%-0.29
Diluted earnings per share	-1,700.00%-0.18	236.36%0.45	-62.50%-0.26	62.50%-0.57	68.97%-0.09	96.15%-0.01	45.00%-0.33	77.78%-0.16	61.90%-1.52	76.61%-0.29
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data